Fund Entrepreneurs Venrock IV Net Worth & Insider Trades
Fund Entrepreneurs Venrock IV Bellerophon Therapeutics, Inc
What is Fund Entrepreneurs Venrock IV's Net Worth?
The current estimated net worth of Bellerophon Therapeutics, Inc's Fund Entrepreneurs Venrock IV is estimated to be about $58.7M . Fund Entrepreneurs Venrock IV owns about 6,435,173 units of Bellerophon Therapeutics, Inc common stock. In the last year at Bellerophon Therapeutics, Inc, Fund Entrepreneurs Venrock IV has sold an estimated value of $524.96K worth.
What is Fund Entrepreneurs Venrock IV's Past Insider Trading?
Fund Entrepreneurs Venrock IV's largest purchase order was 475,000 units , worth over $558.39K on September 12, 2018. Fund Entrepreneurs Venrock IV's largest sale order was 1,093,847 units , worth over $524.96K on October 28, 2019. In total, Fund Entrepreneurs Venrock IV has made about 6 transactions over a year of their time at Bellerophon Therapeutics, Inc. Fund Entrepreneurs Venrock IV usually trades in September, with the busiest year in 2018.
ASSOCIATES VENROCK IV, FUND ENTREPRENEURS VENROCK IV, VEF Management IV LLC, Bong Koh, Venrock Healthcare Capital Partners II LP, Venrock Management IV LLC, Venrock Partners Management LLC, Venrock Partners LP, VHCP CoInvestment Holdings II LLC, VHCP Management II LLC
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Fund Entrepreneurs Venrock IV's' Mailing Address?
- Mailing address is 3340 Hillview Avenue Palo Alto CA 94304 CA
What are Bellerophon Therapeutics, Inc's Past Insider Trades?
Bellerophon Therapeutics, Inc's most recent insider trade came on March 22, 2021 by New Mountain Investments Ii Llc, New Mountain Capital Llc and Steven Klinsky who sold 400,000 units worth $2.19M . In the last 6 years, insiders at Bellerophon Therapeutics, Inc have sold an estimated value of $4.02M and bought an estimated value of $74.83M worth of shares. Insider trading is most common in September, with the busiest year in 2018. The most active traders at the company are Jonathan M Peacock, Theodore T Wang, and Peter Fernandes, CHIEF EXECUTIVE OFFICER .
Bellerophon Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||